Serology News and Research

RSS

Widespread testing could help stop the spread of COVID-19

The world is now in the grips of a historic pandemic. The death toll from the novel coronavirus has climbed to more than 117,000 in the United States and 448,000 around the world.

18 Jun 2020

Testing reveals 11 percent of people in Geneva infected with SARS-CoV-2

Now, a team of researchers at Geneva University Hospitals has found that less than 11 percent of the population in Geneva has contracted the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their research is published in the journal The Lancet.

15 Jun 2020

Seroprevalence of IgM and IgG against SARS-CoV-2 in China

A new study published in the journal Nature Medicine in June 2020 reports the seroprevalence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across China. This may help to understand the actual prevalence of the virus in the current pandemic.

10 Jun 2020

Mitigating "second wave" COVID-19 risk to health frontliners and patients

Researchers at University College London have made important discoveries about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among frontline healthcare workers that could help to inform new policies for protecting staff and patients in the future.

10 Jun 2020

Improving detection of SARS-CoV-2 infection among severely ill children

Researchers in the UK have conducted a study showing that children with a severe inflammatory syndrome had high levels of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), despite having tested negative for the virus by polymerase chain reaction (PCR).

8 Jun 2020

Bioinsider presents "Diagnostic Landscape For COVID19” virtual meeting

Bioinsider LLC (Bioinsider) will present the “Diagnostic Landscape for COVID-19” virtual meeting on Thursday, June 18, 2020.

8 Jun 2020

New initiative to determine extent of COVID-19 infections in Virginia

UVA Health has partnered with the Virginia Department of Health and other hospitals around the state to determine how many Virginians have been infected with COVID-19 - and how many remain at risk.

4 Jun 2020

Hype collides with science as FDA tries to rein in ‘Wild West’ of COVID blood tests

"Save your business while saving lives," reads the website of Because Health, a Seattle tech startup selling two types of tests to employers willing to pay $350 a pop to learn whether their workers have been infected with COVID-19.

3 Jun 2020

IgG antibodies reduce viral load of SARS-CoV-2

A study conducted by researchers at the University of Washington has highlighted the importance of serological testing for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

26 May 2020

Challenges of diagnosing Lyme disease in the absence of classic symptoms

Lyme disease can have unusual presentations. Physicians and the public should be aware of its different manifestations, as people spend more time outside in the warmer weather and as the areas in Canada where the black legged tick is found expand.

26 May 2020

Changes in antibodies and RNA shedding during early SARS-CoV-2 infection

As the COVID-19 pandemic and its far-reaching implications continue to unfold globally and disrupt our normal way of life, scientists and researchers are racing to find an appropriate vaccine or therapeutic drug. This process involves understanding how the virus interacts with the host cell, the dynamics of the host immune response, and the eventual outcome.

22 May 2020

Bioinsider launches COVID-19 virtual meeting series

Bioinsider has opened registration and a call for speaker proposals for its four-part virtual meeting series, Together as One COVID-19 Series.

21 May 2020

Bio-Techne and Kantaro Biosciences announce partnership to develop and scale production of COVID-19 serology test

Bio-Techne Corporation and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced a partnership to initiate scaled manufacturing and distribution of testing kits based on the Mount Sinai-developed COVID-19 serology test.

From Bio-Techne 21 May 2020

Current antibody tests are good enough to inform decisions about public health, say experts

While it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.

20 May 2020

‘Last responders’ seek to expand postmortem COVID testing in unexplained deaths

Examining dead bodies and probing for a cause of death is rarely seen as a heroic or glamorous job. Rather, as the coronavirus pandemic has unfolded, all eyes have been on the medical workers and public health disease detectives fighting on the front lines - and sometimes giving their lives — to bring the novel coronavirus under control.

19 May 2020

Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit

Oxford Immunotec Global PLC, a global, high-growth diagnostics company, today announces the release of the T-SPOT Discovery SARS-CoV-2 test kit.

19 May 2020

SMART researchers awarded NMRC funding to develop rapid paper-based COVID-19 tests

Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, has received a grant from the National Medical Research Council COVID-19 Research fund for the acceleration of research and development of rapid paper-based serological and diagnostic tests for COVID-19.

18 May 2020

UCI partners with Orange County Health Care Agency for large-scale COVID-19 infection survey

It's almost certain that COVID-19 cases across the nation have been vastly undercounted, since people with few to no symptoms - who may be infected but have immunity - are rarely tested.

15 May 2020

COVID survivors’ blood plasma is a sought-after new commodity

Diana Berrent learned she had tested positive for COVID-19 on a Wednesday in mid-March. Within a day, she had received 30 emails from people urging her to donate blood.

11 May 2020

Intervention strategy based on shield immunity could reduce risk of expanding economic activity

While attention remains focused on the number of COVID-19 deaths and new cases, a separate statistic - the number of recovered patients - may be equally important to the goal of minimizing the pandemic's infection rate as shelter-in-place orders are lifted.

8 May 2020